Logo

American Heart Association

  24
  0


Final ID:

Bisecting the Future of HFpEF Therapy: Medical and Procedural Therapy

  • Redfield, Margaret  ( Mayo Clinic-Dr. Margaret Redfield , Rochester , Minnesota , United States )
  • Reza, Nosheen  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
  • Author Disclosures:
    Margaret Redfield: DO NOT have relevant financial relationships | Nosheen Reza: DO have relevant financial relationships ; Research Funding (PI or named investigator):Bristol Myers Squibb:Active (exists now) ; Speaker:Zoll:Past (completed) ; Advisor:American Regent:Past (completed) ; Advisor:Roche Diagnostics:Past (completed)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Featured Science: Getting Closer to the Summit: New HFpEF Treatments

Sunday, 11/17/2024 , 08:00AM - 09:15AM

Featured Science

More abstracts on this topic:
Efficacy and safety of finerenone in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified sex-specific analysis of the FINEARTS-HF trial

Chimura Misato, Lam Carolyn, Senni Michele, Shah Sanjiv, Voors Adriaan, Zannad Faiez, Pitt Bertram, Vaduganathan Muthiah, Solomon Scott, Mcmurray John, Jhund Pardeep, Henderson Alasdair David, Claggett Brian, Desai Akshay, Mueller Katharina, Glasauer Andrea, Rohwedder Katja, Viswanathan Prabhakar

Finerenone and Risk of Hyperkalemia in Patients with Heart failure with Mildly Reduced or Preserved Ejection Fraction

Vardeny Orly, Zannad Faiez, Pitt Bertram, Lay-flurrie James, Viswanathan Prabhakar, Horvat-broecker Andrea, Scalise Andrea, Mcmurray John, Solomon Scott, Vaduganathan Muthiah, Claggett Brian, Desai Akshay, Jhund Pardeep, Lam Carolyn, Senni Michele, Shah Sanjiv, Voors Adriaan

You have to be authorized to contact abstract author. Please, Login
Not Available